会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD FOR PERSONALIZED DIET DESIGN
    • 个性化饮食设计方法
    • US20080171335A1
    • 2008-07-17
    • US11948099
    • 2007-11-30
    • Jose M. OrdovasDolores CorellaChao-Qiang Lai
    • Jose M. OrdovasDolores CorellaChao-Qiang Lai
    • C12Q1/68
    • C12Q1/6883C12Q2600/106C12Q2600/156C12Q2600/172
    • The invention provides methods and kits for designing a diet with a desired fat content for an individual in need thereof to allow the individual to, for example, maintain or reduce healthy weight, manage diabetes, for example by managing weight or accommodate a food allergy. The method comprises determining whether the individual carries APOA5 −1131T and/or C allele or both or any allele in chromosome 11 that is in a tight linkage disequilibrium with said-alleles, wherein if the individual is a homozygote for APOA5 −1131T allele or an allele in tight linkage disequilibrium with APOA5 −1131T allele, the designing of a diet comprises reducing a total fat content of the diet below 30% of total calorie intake and/or reducing the amount of monounsaturated fatty acids in the diet under about 11% of total calorie intake. We surprisingly found that these methods and kits apply to both females and males and to a variety of ethnic backgrounds.
    • 本发明提供了用于为有需要的个体设计具有所需脂肪含量的饮食的方法和试剂盒,以允许个体例如维持或减少健康体重,例如通过控制体重或适应食物过敏来控制糖尿病。 该方法包括确定个体是否携带与所述等位基因处于紧密连锁不平衡中的APOA5 -1131T和/或C等位基因或两者或任何等位基因,其中如果个体是APOA5 -1131T等位基因的纯合子或 等位基因与APOA5 -1131T等位基因紧密连锁不平衡,饮食的设计包括将膳食中总脂肪含量降低至总卡路里摄入量的30%以下,和/或减少饮食中单不饱和脂肪酸的量约11% 总卡路里摄入量 我们惊奇地发现,这些方法和试剂盒适用于女性和男性以及各种种族背景。
    • 6. 发明申请
    • Composition and methods for evaluating an organism's response to alcohol or stimulants
    • 评估生物体对酒精或兴奋剂反应的组成和方法
    • US20060024658A1
    • 2006-02-02
    • US10746794
    • 2003-12-23
    • Michael MilesChao-Qiang LaiDavid Lockhart
    • Michael MilesChao-Qiang LaiDavid Lockhart
    • C12Q1/00C12Q1/68
    • C12Q1/6809C12Q2565/501
    • This invention pertains to the identification of genes whose expression levels are altered by chronic exposure of a cell, tissue, or organism to one or more drugs of abuse (e.g. alcohol, stimulants, opiates, etc.). In one embodiment, this invention provides a method of monitoring the response of a cell a drug of abuse. The method involves contacting the cell with the drug of abuse; providing a biological sample comprising the cell; and detecting, in the sample, the expression of one or more genes or ESTs identified herein, where a difference between the expression of one or more of said genes or ESTs in said sample and one or more of said genes or ESTs in a biological sample not contacted with said drug of abuse indicates a response of the cell to the drug of abuse
    • 本发明涉及通过将细胞,组织或生物体慢性暴露于一种或多种滥用药物(例如酒精,兴奋剂,阿片剂等)来改变其表达水平的基因的鉴定。 在一个实施方案中,本发明提供了监测细胞滥用药物的反应的方法。 该方法包括使细胞与滥用药物接触; 提供包含细胞的生物样品; 并且在样品中检测本文鉴定的一种或多种基因或EST的表达,其中所述样品中的一种或多种所述基因或EST的表达与生物样品中的所述基因或EST中的一种或多种之间的差异 没有与所述滥用药物联系表示细胞对滥用药物的反应